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1. Introduction 
This chapter focuses on the potential contributions of the blood-borne neutrophils to 
hypercholesterolemia-related pathophysiology (e.g., thrombus formation, embolism, heart 
attack, stroke, etc.). Neutrophils are immersed in the cholesterol-abundant plasma of 
blood and play critical roles in the acute inflammatory response of the body to infection or 
tissue damage. Because of their high degree of sensitivity to inflammatory agonists and 
their arsenal of potent microbicidal and tissue degradative agents, a number of redundant 
cellular mechanisms exist to control or “turn-off” the inflammatory processes by these 
cells under physiological (non-pathological) conditions. Failure of these mechanisms leads 
to sustained levels of cell activity that contribute to a chronic inflammatory phenotype 
with the continuous release of proteases and cytokines as well as the potential to elicit 
non-specific damage to host tissues. Alternatively, chronic neutrophil activity may impair 
tissue perfusion via its effects on the rheological flow behavior of blood particularly in 
terms of the ability of leukocytes to transit the microcirculation[1]. Such potential damage 
mechanisms are thought to govern an increasing number of human pathological scenarios 
(e.g., Alzheimer’s, diabetes, vascular disease) that correlate with a chronic inflammatory 
state. In this regard, chronic inflammation has gained recognition in the scientific 
community and even in the mainstream national media (e.g., Time[2] and Newsweek[3] 
magazines) as a common denominator for human diseases. The question is whether the 
dysregulation of neutrophil activity is a significant component of this potential disease 
mechanism. 
We address this issue from a mechanobiological perspective by presenting evidence that 
supports a role of impaired neutrophil mechanotransduction of hemodynamics-derived 
fluid flow in the pathogenesis of hypercholesterolemia-linked diseases. For this purpose, we 
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will first discuss the link between chronic inflammation and hypercholesterolemia and then 
highlight the neutrophil involvement in the pathophysiology of related cardiovascular 
diseases, e.g. atherosclerosis and microvascular dysfunction. To further exemplify this 
link, we will explain the potential mechanism(s) by which cholesterol in blood may 
impact the biochemical regulation of neutrophil activity at the cellular level. Finally, we 
will introduce our own evidence as well as those of others pointing to dysregulated 
neutrophil mechanotransduction as an important component of hypercholesterolemic 
pathologies. 
2. Hypercholesterolemia and chronic inflammation  
Hypercholesterolemia is the dominant risk factor for atherosclerosis and its downstream 
complications (e.g., heart attack, stroke, etc.). Over the past two decades, a wealth of insight 
has pointed to the development of atherosclerotic lesions in the large vessels (e.g., aorta, 
carotid, femoral artery, etc.) as occurring at the interface between hypercholesterolemia and 
inflammation (see reviews[4, 5]). According to the current paradigm, at atheroma-prone 
sites, inflamed endothelial cells (due to damage or dysregulation) initiate the invasion of 
blood leukocytes (predominantly, monocytes) and smooth muscle cells (SMCs) into the 
subendothelial (e.g., the intimal) layer of the vascular wall contributing to atherosclerotic 
tissue remodeling, thrombosis, and finally embolus formation. The main lipid species that 
appear to dominate this inflammatory process are modified low-density lipoprotein (LDL) 
particles, particularly oxidized LDL (oxLDL), which act as potent proatherogenic and 
proinflammatory factors responsible for not only loading monocyte-derived macrophages 
with cholesterol but also directly stimulating leukocytes and other vascular wall cells (for a 
more complete explanation, see reviews[5, 6]).  
Hypercholesterolemia also induces chronic inflammation in the microcirculation[7]. 
Phenotypic changes in the microvasculature are observed long before the appearance of 
fatty streak lesions in the large arteries of animals placed on high fat (HFD), i.e. 
proatherogenic, diet[8, 9]. The inflammatory phenotype of the microvessels in 
hypercholesterolemic animals results in increased basal levels of rolling, adherent, and 
emigrating leukocytes in the postcapillary venules, predominantly neutrophils, as well as 
enhanced production of reactive oxygen species (ROS). Hypercholesterolemia also 
exaggerates microvascular responses to a range of proinflammatory stimuli. For example, 
the postcapillary venules of LDL receptor deficient (LDLr-/-) mice, a murine model of 
modest hypercholesterolemia (with 3-fold higher levels of plasma cholesterol compared to 
their wild-type (WT) counterparts), exhibit enhanced leukocyte adhesion and albumin 
leakage in response to experimental ischemia/reperfusion injury as compared to those of 
WT mice[10]. Interestingly, similar phenotypic changes can be observed in the 
microvasculature of normocholesterolemic animals administered oxLDL[11, 12], suggesting 
that oxLDL participates in hypercholesterolemia-related microvascular dysfunction.  
Although the mechanisms responsible for the induction of inflammation by 
hypercholesterolemia in both microvessels and larger arteries remain unclear, it appears 
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that they both begin with endothelial dysfunction characterized by reduced vasodilation, a 
proinflammatory state, and enhanced permeability to macromolecules (e.g., lipids). 
However, the original triggers for this endothelial dysfunction are still controversial. In this 
regard, oxLDL, based on its potent proinflammatory effects, has been considered as a 
candidate that initiates the inflammatory responses. In fact, production and release of ROS 
and myeloperoxidase (MPO)[13], which play critical roles in the oxidation of LDL-
cholesterol conjugates and are tightly controlled under the physiological non-inflamed 
conditions, increase in response to hypercholesterolemia. The cellular basis for the causality 
between oxLDL formation and chronic inflammation, however, remains elusive.  
Interestingly, the preferential formation of atherosclerotic lesions at bifurcations, severe 
curvatures, and stenoses in the arterial circulation strongly suggests that the hemodynamic 
flow environment is an important determinant in atherogenesis. Fluid flow-derived 
frictional (i.e., shear) stresses imposed on the surfaces of endothelium lining the vascular 
wall have been shown to serve an atheroprotective function when blood flow is laminar (i.e., 
smooth and ordered; for a more comprehensive discussion, see review[14]). For example, 
laminar fluid flow stimulates endothelial production of nitric oxide (NO), with vasodilatory 
and anti-inflammatory actions[15]. In contrast, oscillatory shear stresses enhance production 
and release of ROS[16]. In addition, disturbed flows lead to the upregulation of adhesion 
molecules on the endothelial surface (e.g., intercellular adhesion molecule-1 or ICAM-1) 
responsible for recruiting leukocytes to the vascular wall[17]. In effect, generation of 
complex distributions of fluid shear stresses on the vascular wall, such as at sites of 
bifurcations and branch points, appears to shift the endothelial phenotype from 
atheroprotective to proatherogenic.  
However, complex flow fields are not sufficient for the onset/progression of 
hypercholesterolemia-related atherosclerosis since, for example, we are born with 
bifurcations and curvatures but do not develop atherosclerosis from birth. It is, therefore, 
clear that cardiovascular pathobiology due to hypercholesterolemia occurs at the 
intersection between vascular cell biology and the surrounding fluid stress environment. In 
this regard, it may be the sensitivity (i.e., responsiveness) of vascular cells to fluid shear 
stress that is altered in the face of hypercholesterolemia leading to a proinflammatory and a 
proatherogenic phenotype. Moreover, the endothelial cells are not the only cells in the 
vasculature. Neutrophils also exist in the cholesterol-enriched, fluid flow environment of the 
circulation and are critical for initiating acute inflammation. Recently, a growing body of 
evidence supporting the involvement of neutrophils has emerged.  
3. The neutrophil involvement in hypercholesterolemia-related vascular 
dysfunction  
Neutrophils make up the majority of the nucleated leukocytes in human blood with the 
remaining being monocytes and lymphocytes. As the principal gatekeepers of the acute 
inflammatory response of the body’s immune system, neutrophils are extremely sensitive to 
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inflammatory stimuli allowing them to rapidly (i.e., on the order of milliseconds) transition 
from an inactivated to an activated state. Upon activation, the upregulation of cell-cell 
adhesion molecules (e.g., selectins, integrins) enables neutrophils to roll and adhere onto the 
endothelium prior to their transmigration (via diapedesis) across the vascular wall and to 
the target tissues (i.e., sites of infection and tissue injury) where they release a potent array 
of biochemicals including proinflammatory mediators, ROS, and proteases to fight infection 
and orchestrate tissue repair. During this process, neutrophils also undergo changes in their 
physical attributes such as their size, deformability, and adhesiveness. It is these features 
that cause neutrophils to be major players in the pathobiology of hypercholesterolemia-
related cardiovascular diseases for both the macro- and micro- circulations.  
3.1. Potential roles of neutrophils in atherosclerosis  
While it has long been appreciated that monocytes and their descendants, along with T 
lymphocytes, mast cells, and platelets, contribute to the development and destabilization of 
atherosclerotic lesions, only recently has the neutrophil been seriously considered as a 
contributing factor for disease onset and/or progression. Direct evidence comes from the 
identification of neutrophils in different locations of atherosclerotic lesions present in 
hypercholesterolemic mice and humans using antibodies to neutrophil-specific antigens 
including Ly6G, CD177, and CD66b[18-21]. Neutrophils, in fact, have been reported to 
accumulate in atheroprone arteries preceding plaque formation in hypercholesterolemic 
murine models of atherosclerosis[18, 20]. Further evidence of a neutrophilic component in the 
early stages of atherosclerosis is the positive correlation between the number of circulating 
neutrophils and lesion sizes[18]. Experimental data also point to neutrophil infiltration into the 
highly inflamed areas of atherosclerotic arteries during late disease stages[19] with 
contribution to lesion destabilization and thromboembolus formation[21, 22].  
One way chronically activated neutrophils may enter atheroprone regions in the 
macrocirculation are at sites of disturbed flow and recirculation[23] where their enhanced 
residence times promote capture at the vascular wall[24]. Alternatively, activated 
neutrophils may disrupt vascular (i.e., adventitial or medial) wall perfusion in the vasa 
vasorum (or microcirculation) of large vessels (e.g., aorta) leading to vessel tissue injury 
followed by atherogenesis (from within the vessel wall to the luminal surface)[25-27]. In 
these ways, neutrophils may initiate or exacerbate atherosclerosis at different stages via 
their capability to release vast amounts of ROS and proteins stored in their cytosolic 
granules[28]. For example, while MPO released by activated neutrophils can reduce the 
bioavailability of NO[29, 30] and contribute to the onset of endothelial dysfunction, a 
number of granule proteins, such as LL-37, azurocidin, cathepsin G, and -defensins, exert 
direct chemotactic activity for monocytes[31, 32]. Moreover, neutrophil secretory products, 
e.g., -defensins, also promote macrophage maturation and activation, contributing to the 
uptake of oxLDL and the formation of foam cells[28]. Finally, neutrophil-derived proteolytic 
enzymes, particularly matrix metalloproteinase (MMP) -2 and -9[28], play critical roles in 
plaque destabilization and eventual rupture.  
 
Linking the Pathobiology of Hypercholesterolemia with the Neutrophil Mechanotransduction 227 
3.2. Effects of neutrophils on microvascular dysfunction 
Similar to situations in large arteries, activated neutrophils promote microvascular 
dysfunction through the sustained release of proinflammatory, cytotoxic, and degradative 
agents. However, while leukocytes have no significant effect on the macrovascular flow 
properties of blood (which is dominated by the substantially greater numbers of 
erythrocytes), these cells, particularly the neutrophils, influence blood flow in the 
microcirculation (Figure 1). This is because vessel diameters in the microcirculation are in 
the range of 6 – 100 m, which are comparable in size to the diameters of leukocytes.  
 
Figure 1. Potential rheological effects of leukocyte activation on the blood flow in the 
microcirculation. Sustained activation, e.g., due to proinflammatory stimuli, hinders leukocyte passage 
through the small vessels either by promoting pseudopod projections or through enabling cell adhesion 
to the vascular wall. Ultimately, these may elevate peripheral resistance and contribute to microvascular 
dysfunctions (adapted from Shin, H.Y., et al., 2011[79]). 
The relatively comparable size scales of the neutrophil and vessel diameters are important 
to note since the quiescent neutrophil under physiological (i.e., non-inflamed) conditions 
is capable of efficient transit through the microvessels due to their inherently round, 
deformable, and non-adhesive state. On the other hand, cell activation physically hinders 
the passage of neutrophils through the small vessels of the microcirculation[1]. 
Pseudopods projected by activated neutrophils, while enabling cells to attach to other 
cells (e.g., endothelial cells, other blood cells) or phagocytose particles, also contribute to a 
reduction in cell deformability due to their enriched content of F-actin, and increases in 
geometric size and irregularity[1, 33], all of which serve to increase leukocyte transit time 
or enhance leukocyte retention in the microvasculature[34, 35]. In turn, activated 
leukocytes disrupt the motion of erythrocytes, leading to increases in the apparent 
viscosity of blood and microvascular resistance[1, 34, 36, 37]. Moreover, activated 
neutrophils are hyperadhesive and exhibit extensive interactions with other leukocytes or 
platelets, e.g. during hypercholesterolemia[7], which may also enhance the apparent 
viscosity of blood. Finally, once neutrophils adhere to endothelium, they further increase 
flow resistance by reducing microvessel diameters (resistance ∝ 1/[diameter]4)[34, 37]. The 
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state of neutrophil activation is, thus, a critical determinant of tissue blood flow and 
perfusion.  
In summary, as a result of their arsenal of noxious agents and their effects on microvascular 
blood flow, it is evident that tight regulation of neutrophil activity is an essential 
requirement for a healthy circulation. A failure to either prevent or “turn-off” cell activity, 
e.g., due to hypercholesterolemia, leads to sustained neutrophil activation which has 
potential impacts not only in terms of the initiation and progression of atherosclerosis in 
large arteries but also as it relates to microvascular blood flow and downstream tissue 
perfusion.  
4. The influence of cholesterol on neutrophil activity 
One way hypercholesterolemia may influence the activation state of neutrophils is to modify 
the lipid composition of biological membranes. Cholesterol is an essential component of 
mammalian cell membranes. Approximately 90% of the free (i.e. unesterified) cholesterol in 
cells resides in the plasma membrane[38]. These sterol molecules not only maintain the 
integrity of cell membranes, but also play an important role in regulating membrane 
properties (e.g., microviscosity) and functions (e.g., via their influence on membrane-bound 
signaling components). In addition to de novo biosynthesis, mammalian cells can take up 
cholesterol from the extracellular milieu. Exposure to elevated cholesterol levels both in vivo 
and in vitro enhances cholesterol abundance within the plasma membrane of neutrophils 
and other blood cells[39-42]. These findings, in conjunction with the wealth of evidence 
demonstrating the influence of the extracellular cholesterol levels on neutrophil activity, 
point to membrane cholesterol enrichment as a potential link between hypercholesterolemia 
and chronic neutrophil activity. To better understand this link, we next describe the possible 
cholesterol uptake pathways, the influence of cholesterol on physicochemical properties of 
the cell membrane, and lastly, the influence of cholesterol on neutrophil activity. 
4.1. Transport of extracellular cholesterol into the plasma membrane  
Due to its insolubility in aqueous media, cholesterol must be transported complexed to 
carrier molecules, i.e. within the hydrophobic cores of lipoproteins[43]. Lipoproteins (e.g., 
LDL) in the blood plasma are positioned in close proximity to the circulating blood cells. 
Conditions that elevate cholesterol-enriched lipoprotein levels may thus favor cholesterol 
transport into the membranes of these blood cells[39, 42]. In the laboratory, cyclodextrin 
derivatives (e.g., methyl--cyclodextrin or MCD), synthetic cholesterol carrier molecules, 
are commonly used to alter membrane cholesterol abundance. Such treatments elicit acute 
changes in membrane cholesterol levels and downstream cell activity indicating the 
existence of mechanism(s) that permit rapid transport of cholesterol into nearby cell 
membranes. Cholesterol uptake may occur by either receptor dependent/independent 
endocytosis followed by rapid membrane mobilization[44] or direct exchange between the 
hydrophobic environments of carrier molecules and the lipid bilayer(Figure 2). 
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4.1.1. Receptor-dependent endocytosis 
For a variety of cell types (including leukocytes)[45], LDL-cholesterol is taken up in vivo 
mainly through LDL receptor (LDLr)-mediated endocytosis. LDLr expression is subject to 
feedback regulation and, thus, is unlikely to contribute significantly to the overaccumulation 
of cellular cholesterol[43]. Cellular uptake of cholesterol can also occur via endocytosis 
mediated by other receptors[43]. Potentially, these pathways can load cholesterol 
continuously into the cell leading to cholesterol elevations in the plasma membrane[43]. For 
example, a family of scavenger receptors have been identified on monocytes, macrophages, 
and SMCs[6] that, by binding to modified LDL (e.g., oxidized and acetylated LDL) with 
high affinity, account for the majority of cholesterol uptake by these cells[6]. To our 
knowledge, such scavenger receptors have not yet been identified for neutrophils. 
 
Figure 2. Schematic representation of three possible modes of cholesterol uptake. A: Receptor-
mediated endocytosis; B: Direct surface exchange of cholesterol between extracellular carrier molecules 
and plasma membrane which may occur due to the formation of a transient collision complex without  
(➀) or with (➁) membrane fusion or resulting from diffusion across the aqueous phase (➂);  
C: Receptor-independent endocytosis.  
4.1.2. Receptor-independent endocytosis 
The entire LDL particle can be internalized as a result of fluid or bulk endocytosis without 
receptor-mediated LDL binding to the cell surface[46]. It is taken up at a rate strictly 
proportional to its concentration in the extracellular milieu[43]. Alternatively, some LDL, 
e.g., cationized LDL, can also be taken up by the cell through a non-specific low affinity 
adsorptive endocytotic process. In this case, endocytosis occurs after cationized LDL binds 
to the negatively charged membrane surface[47]. For both of these modes of endocytosis, 
cholesterol transport is not influenced by intracellular cholesterol levels and thus may lead 
to progressive cholesterol uptake[43].  
4.1.3. Cholesterol surface exchange 
Cholesterol may also directly enter or exit the plasma membrane[48]. In this case, free 
cholesterol is exchanged between the hydrophobic cores of the plasma membrane and 
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extracellular carriers (e.g., lipoproteins). The direction of net flux of cholesterol is governed 
by its concentration gradient between the lipid bilayer and the carrier molecules. Two 
mechanisms for this surface transfer have been proposed: 1) formation of transient collision 
complexes with/without membrane fusion and 2) direct diffusion across the aqueous phase. 
In principle, these transport modes follow similar kinetics with transfer rates depending on 
the concentrations and structures of both donor (e.g., extracellular LDL) and acceptor (e.g., 
cells) particles (for more details, see review[48]). This level of complexity contributes, in 
part, to the diverse half-times ranging from seconds to hours measured for the uptake of 
cholesterol by human erythrocytes[49]. Finally, this pathway is not under feedback control.  
4.2. The influence of cholesterol on the plasma membrane dynamics 
In the lipid bilayer, cholesterol orients with its polar hydroxyl group encountering the 
aqueous phase and the hydrophobic steroid ring parallel to and buried in the hydrocarbon 
chains of the phospholipids[50]. This unique orientation allows cholesterol to interact with 
membrane phospholipids and sphingolipids and thus influence their physicochemistry. 
Along these lines, cholesterol influences the physical and biological properties of the lipid 
bilayer and, in doing so, impacts the functions of membrane signaling molecules.  
4.2.1. Effects of cholesterol on the physical properties of cellular membranes 
A key function of cholesterol is to modulate the fluidity (i.e., the inverse of microviscosity) 
of the lipid bilayer. The close inter-positioning of sterols (i.e., cholesterol) between 
neighboring membrane phospholipids imposes a degree of immobility on the carbon 
atoms nearest the membrane surface, while increasing the freedom of motion deep within 
the hydrophobic core of the membrane[51]. In this regard, membrane fluidity reflects the 
temperature-dependent influence of cholesterol on the gel to liquid-crystal (i.e., solid-like 
to fluid-like) phase transition of the lipid bilayer[51]. Under physiological conditions (i.e., 
37oC), biological membranes adopt a liquid crystalline state whereby increases and 
decreases in cholesterol content reduce and enhance membrane fluidity, respectively[42, 
52, 53].  
Operationally, membrane fluidity refers to the ensemble of physical properties that govern 
the motion of the phospholipid molecules in a membrane, including segmental, rotational, 
lateral, and translational motions[54]. In this fashion, lipid bilayer fluidity can physically 
influence the dynamics of membrane-associated molecules including proteins that drive 
downstream cell functions. Two mechanisms have been proposed to explain how 
membrane fluidity alters the activities and functions of membrane proteins. One mechanism 
occurs through effects on protein mobility, particularly lateral diffusion which impacts 
collisional encounters[54]. This effect appears to be of physiological significance particularly 
for diffusion-controlled processes that are mediated by large membrane proteins. For 
example, modulation of membrane fluidity influences Ca++-dependent cAMP signaling 
through changes in protein mobility that governs the coupling between hormone receptors 
and the adenylate cyclase catalytic unit[55, 56]. Alternatively, membrane fluidity can also 
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influence the structural flexibility of membrane proteins and, thus, their ability to adopt an 
optimal conformation for activity[57]. Membrane fluidity has, in fact, been reported to 
impact the conformation-dependent activation of G-protein coupled receptors (GPCRs) on 
endothelial cells by affecting changes in the protein tertiary structure[58].  
4.2.2. Role of cholesterol in lipid raft structure and function 
Lipid rafts are nano-scale microdomains that are abundant in the plasma membrane. 
Structurally, lipid rafts consist of dynamic assemblies of cholesterol and sphingolipids in the 
outer leaflet of the phospholipid bilayer[59]. The preponderance of saturated hydrocarbon 
chains in raft sphingolipids renders lipid rafts with a distinct liquid-ordered (i.e., solid-like) 
phase that is dispersed in the liquid-disordered matrix of the lipid bilayer[60]. One 
important property of lipid rafts is that they include or exclude proteins to variable extents 
depending on the raft affinity of proteins[59]. Once individual rafts cluster, they spatially 
facilitate interactions between raft proteins and expose them to a new membrane 
environment that is enriched in accessory enzymes and/or second-messenger molecules. In 
doing so, lipid rafts serve to efficiently initiate and/or amplify signaling cascades. As such, 
lipid rafts act as signaling platforms that orchestrate outside-in and inside-out signal 
transduction. Interestingly, these cholesterol-rich microdomains have also been implicated 
as mechanotransduction centers such as caveolae, a subtype of lipid rafts that reportedly 
play a role in endothelial mechanotransduction of shear stress and pressure[61-63].  
Cholesterol is required to support the formation of lipid rafts and maintain their 
functionality. It condenses the packing of sphingolipids in the exoplasmic leaflet by 
occupying the spaces between their saturated hydrocarbon chains near the hydrophilic 
polar head groups. In this way, cholesterol content and organization influence the stability 
of lipid rafts with an impact on their capacity to interact with target proteins. Removal or 
depletion of cholesterol from the plasma membrane using MCD has been widely used to 
disrupt rafts and disperse raft proteins into the liquid-disordered matrix of the cell 
membrane[59]. Treatment of cells with cholesterol-sequestering agents (e.g., filipin or 
nystatin) or inhibition of cholesterol biosynthesis (e.g., lovastatin) as well as addition of 
exogenous cholesterol into cell membranes also disrupts raft structure leading to an impact 
on the functions of raft proteins[59]. As a consequence of these lipid raft-related 
perturbations, neutrophil functions (e.g., chemokine-induced calcium signaling, 
extracellular regulated kinase activity, cell polarization, shape change, adhesion, migration, 
integrin expression, and actin polymerization) are altered[64-68].  
4.3. Effects of elevated cholesterol environments on neutrophil activity 
Up to this point, we have described how perturbations in extracellular cholesterol levels 
modify the membrane physicochemistry and the mode by which these modifications may 
influence membrane protein-related signaling in the neutrophil. The altered cell signaling 
capacity of membrane-bound proteins is followed by changes in cell behavior that 
contribute to the principal role of the neutrophil as the first responder to tissue damage and 
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infection. In this way, the influence of membrane cholesterol on the ability of the neutrophil 
to sense its environment extends to basic cell functions including cell adhesion and 
migration, phagocytosis, ROS production, and degranulation. We will discuss the effects of 
cholesterol on these cell functions in order to illustrate the link between the lipid bilayer 
properties and the control of neutrophil activation. 
4.3.1. Expression of membrane adhesion molecules  
Upon agonist stimulation, neutrophils exhibit upregulated expression of adhesion 
molecules that facilitate their recruitment to sites of inflammation by enabling their binding 
to other cells (e.g., leukocytes, platelets, endothelium)[33]. Two classes of adhesion 
molecules govern leukocyte interactions with other cells: selectins and integrins. In addition 
to the ligands for platelet (P)- or endothelial (E)- selectins, neutrophils constitutively express 
leukocyte (L)-selectins and 2 (i.e., CD18) integrins, which participate in their initial capture 
and firm adhesion to other cells, respectively[33]. Currently, the impact of 
hypercholesterolemia on expression of the selectin family of adhesion molecules is unclear 
since neutrophils in a cholesterol-rich environment have been reported to exhibit both 
elevated surface expression[69] and cleavage of L-selectins[70]. In the case of the integrins, 
surface levels of CD18, particularly Mac-1 (CD11b/CD18), are elevated on neutrophils 
exposed to a hypercholesterolemic environment both in vitro and in vivo[29, 69, 70]. 
Notably, surface expression of Mac-1 by neutrophils in hypercholesterolemic patients 
positively correlates with serum cholesterol levels[29]. But, cholesterol enrichment does not 
appear to alter the expression of LFA-1 (CD11a/CD18)[69], another CD18 subtype. Thus, the 
influence of extracellular cholesterol levels on neutrophil adhesion molecule expression is 
receptor-specific.  
Moreover, neutrophils exposed to elevated cholesterol levels undergo increased adhesive 
interactions with other cells. For example, neutrophils with increased membrane cholesterol 
exhibit enhanced tethering and firm arrest on activated endothelial cell monolayers[41, 71, 
72]. Moreover, neutrophils exposed to hypercholesterolemia display increased heterotypic 
adhesion to platelets[73] as well as increased homotypic aggregation in response to 10 M 
N-formyl-Met-Leu-Phe (fMLP)[74]. These studies confirm that cholesterol-dependent 
modulation of adhesion molecule expression has an impact on neutrophil adhesion to other 
leukocytes, platelets, or the endothelium lining the blood vessel lumen.  
4.3.2. ROS production 
Neutrophil-derived ROS includes superoxide (O2-), hydrogen peroxide (H2O2), hydroxyl 
radicals (-OH), and NO-related oxidants. Notably, total production of ROS by neutrophils in 
a hyperlipidemic environment positively correlates with levels of triglycerides and LDL but 
not with total amount of cholesterol in the plasma[75]. Recent studies, however, did 
demonstrate a positive correlation between O2- release rate and plasma cholesterol 
levels[29]. Interestingly, enhanced O2- release by neutrophils was detected in other clinical 
states associated with cardiovascular complications, namely hypertension and diabetes[76, 
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77], which are usually accompanied by hyperlipidemia. In fact, elevations in extracellular 
cholesterol levels have been shown to enhance neutrophil respiratory burst in response to 
agonist stimulation. Moreover, plasma activity of superoxide dismutase (SOD), which 
scavenges ROS, decreases with increases in total cholesterol[75].  
4.3.3. Degranulation  
Neutrophils contain four main types of granules: primary, secondary, and tertiary granules 
as well as secretory vesicles. These granules contain a multitude of cytokines (e.g., 
interleukins, tumor necrosis factor-, etc.), enzymes (e.g., MPO, etc.), and proteases (e.g., 
cathepsins, MMPs, etc.). Upon activation, neutrophils degranulate and release these 
bioactive mediators into the extracellular milieu. Interestingly, although neutrophils from 
hyperlipidemic patients contain significantly lower levels of intracellular MPO, sera from 
these patients exhibit significantly higher levels of MPO[29]. These results point to a 
degranulation process that further links the activation state of neutrophils with the 
cholesterol levels in the blood environment. 
5. Membrane cholesterol and the neutrophil mechanosensitivity to shear 
stress  
In addition to the presence of inflammatory stimuli (e.g., oxLDL), elevated neutrophil 
activity in hypercholesterolemia may result from defects in their mechanotransduction of 
fluid shear stress, a control mechanism to prevent spontaneous neutrophil activity under 
physiological conditions[78, 79]. In this regard, the mechanosensitivity of neutrophils may 
serve as a key regulator of the inflammatory status of the circulation. We will first define the 
leukocyte mechanosensitivity to shear followed by a brief discussion of cellular mechanisms 
that link the extracellular flow environment to downstream neutrophil functions. 
Interestingly, such mechanotransduction processes occur across the plasma membrane that 
plays a critical role in regulating the activity of membrane proteins as well as the 
transmembrane movement of bioactive molecules. The direct contact of cell membrane with 
the extracellular flow environment makes it a likely target of local environmental factors 
(e.g., enhanced cholesterol abundance) that influence the neutrophil responsiveness to 
mechanical stimuli.  
5.1. Regulation of neutrophil activity by fluid flow-derived shear stress 
Neutrophils, either freely suspended in the bloodstream or adhered to/migrating on 
vascular endothelium, sense and respond to fluid shear stress[80-82]. Fluid shear stress 
(ranging from approximately 1 to 10 dyn/cm2) minimizes neutrophil activity levels[78]. The 
most obvious manifestation of the cell-inactivating effects of shear exposure on cell activity 
is the retraction of existing pseudopodia by non-cytokine-stimulated human neutrophils 
adhered to a surface and subjected to a non-uniform flow field imposed by a micropipette 
with a tip of diameter in the range of 4 – 8 μm[82] (Figure 3A). This situation models brief 
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and spontaneous periods of blood stasis followed by reperfusion, a typical scenario in the 
microvessels. Under this condition, neutrophils sediment, attach, extend pseudopods, and 
migrate on the vascular endothelium. Upon reintroduction of fluid flow, these cells retract 
pseudopods and detach into the flow field in a mechanobiological fashion. Such a scenario 
has been documented using intravital microscopy of microvascular networks of rodents 
(e.g., mesentery, spinotrapezius muscle, cremaster muscle)[81-83]. The ability of shear stress 
to minimize pseudopod activity has been further confirmed for non-adherent heterogeneous 
leukocyte populations[84] exposed to a constant shear field (5 dyn/cm2) in a cone-plate 
viscometer (Figure 3B).  
 
Figure 3. Deactivation of neutrophils under flow stimulation. A: A migrating/adherent neutrophil 
exposed to a micropipette flow (~ 2 dyn/cm2) for 2 min. B: Non-adherent neutrophils in suspension 
exposed to cone-plate shear (5 dyn/cm2) for 10 min. Bars are mean percentage of activated cells with 
pseudopods (see image insets) in each population tested ± SEM; *p < 0.05 compared to static condition 
using paired Student’s t-test.  
Notably, impairment of shear-induced pseudopod retraction by treating neutrophils with 
cell agonists above threshold concentrations, e.g. fMLP (>10-8 M), commits these cells to an 
activated (inflamed) phenotype and leads to their microvascular entrapment due to 
increases in adhesivity, size, and stiffness[35, 81, 82]. Thus, during inflammation, the 
biochemical milieu of the neutrophil overrides mechanobiological deactivation. Exposure to 
shear of magnitudes typically found in the macro- and micro- circulations is also associated 
with other attributes of neutrophil deactivation such as decreased surface expression of 
integrin receptors (i.e., CD18), depolymerization of the F-actin cytoskeleton, cell 
detachment, and attenuated phagocytic activity[81, 82]. Moreover, shear stress exposure 
enhances caspase 3-dependent apoptosis[85], in line with the relatively short lifespan (18 to 
24 hrs) of these cells when they are passively circulating in the physiologic bloodstream. 
These observations support the key role of fluid flow-related shear stress as a biophysical 
stimulus that promotes neutrophil inactivation when cell activity is below a threshold level. 
As such, the mechanical influence of fluid flow serves an anti-inflammatory role. 
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5.2. Shear stress mechanotransduction at the neutrophil surface 
An understanding of the fluid flow mechanoregulation of neutrophil activity in the 
circulation reveals clues regarding how impaired mechanosensitivity to flow may be a 
mitigating factor for hypercholesterolemic disorders. Membrane detachment during 
pseudopod retraction by migrating neutrophils in response to fluid shear stress points to 
two fundamental requirements that must be fulfilled by the cell signaling apparatus: 1) 
depolymerization of the F-actin cytoskeleton that serves as a structural and a signaling 
scaffold for neutrophil motility and 2) rapid disengagement of adhesion receptors that 
anchor the pseudopod to the underlying substrates. For suspended neutrophils, similar 
events are needed but, in this case, mechanisms must be in place to prevent the expression 
of adhesive proteins or interfere with engagement of adhesion molecule with substrates (e.g. 
foreign surfaces, other cells) presenting counter-receptors. These fundamental requirements 
point to the neutrophil surface components as critical players in mechanotransduction since 
the cell must sense the extracellular flow environment and remediate its interactions with 
the cellular microenvironment (e.g., the surrounding matrix and cells). 
5.2.1. GPCRs and shear stress control of neutrophil pseudopod activity 
Shear stress-induced pseudopod retraction by neutrophils occurs in parallel with a rapid 
decrease in F-actin content[86, 87]. Typically, remodeling of the F-actin cytoskeleton in 
leukocytes is controlled by the Ras superfamily of small guanine triphosphate (GTP)-
binding proteins, particularly the small GTP-binding phosphatases (GTPases) including 
Rac1, Rac2, cdc42 and members of the Rho family (as reviewed in the literature[88-90]). 
Rather than stimulating the activity of molecules that coordinate pseudopod retraction (e.g., 
RhoA, MLCK), fluid shear stress appears to either inhibit (e.g., possibly through release of 
an inhibitor) or interfere with the ability of neutrophils to form and sustain pseudopod 
projections via reducing cytosolic activity of the key small GTPases (e.g., Rac1, Rac2) 
involved in actin polymerization[83]. These reported effects point to the actions of fluid 
shear stress on G protein signaling downstream of GPCRs that regulate neutrophil 
chemotaxis, such as the formyl peptide receptor (FPR).  
Notably, fMLP, a ligand for FPR, dose-dependently impairs neutrophil pseudopod 
retraction responses to shear stimulation[81]. Along this line, HL-60-derived neutrophils 
subjected to shear stress exhibit reduced activity of Gαi downstream of FPR[91]. A critical 
piece of evidence pointing to FPR as a mechanosensory regulator of pseudopod retraction is 
the observation that transfection of FPR expression plasmid in undifferentiated HL-60 cells 
not only confers expression of this receptor but imparts on these cells the ability to form 
pseudopods that retract under the influence of fluid shear stress[91]. Furthermore, HL-60 
promyelocytes differentiated into neutrophils and subsequently transfected with siRNA to 
silence FPR expression exhibit an attenuated pseudopod retraction response to shear 
exposure, despite the fact that these cells retain the ability to project pseudopods because of 
the presence of other cytokine-related GPCRs[91]. Together, these observations point to a 
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role of fluid flow in regulating the activity of membrane-associated receptors by establishing 
the importance of membrane-bound GPCRs, specifically FPR, in the neutrophil pseudopod 
retraction response to shear stress. In conjunction with the dependence of GPCR activity on 
the membrane cholesterol content, it is conceivable that the influence of shear stress on 
GPCR activity is impacted by perturbations in extracellular cholesterol abundance and their 
effects on the cell membrane properties. 
5.2.2. Cell surface CD18 integrins and shear stress regulation of neutrophil adhesion 
Pseudopod retraction by migrating neutrophils subjected to fluid flow depends on their 
expression levels of CD18 integrins[92], consistent with the requirement of these receptors 
for cyclical pseudopod projection and retraction[93]. In addition to modulating CD18 
interactions with their ligands (e.g. ICAM-1) during inflammation[94, 95], fluid shear stress 
appears to regulate integrin dynamics on the neutrophil surface under conditions that 
mimic low activation states by redistributing these receptors from areas of maximal shear 
stress to regions where shear is minimal, i.e. at focal adhesions. Moreover, shear exposure 
reduces CD18 levels on the surfaces of migrating, and also non-adherent, neutrophils even 
in the presence of inflammatory mediators, e.g. fMLP[81, 96]. Considering the role of CD18 
in strengthening neutrophil attachment to the vascular wall, shear-mediated reductions in 
CD18 likely diminish the ability of cells to maintain adhesive attachments[97]. In this way, 
shear-mediated reductions in CD18 serve an anti-inflammatory role that ensures neutrophils 
in a non-inflamed environment remain in a non-adhesive state.  
The mechanism underlying shear-induced reductions in CD18 surface levels involves 
proteolysis that occurs on the surfaces of migrating and suspended neutrophils. Proteolysis 
modulates the levels of a wide variety of transmembrane receptors on the neutrophil surface 
including L-selectin (involved in rolling interactions with endothelium)[98] and CD43, an 
anti-adhesive mucin-like molecule[99]. CD18 integrins also undergo cleavage of the 
intracellular domain by calpain to promote detachment of the cell uropod during neutrophil 
migration[100]. But shear-induced truncation of CD18 integrins differs from calpain-
mediated cleavage in that the former involves lysosomal cysteine proteases (e.g., cathepsin 
B) that exert extracellular activity[96, 97]. Notably, the cell membrane is critically positioned 
between the intracellular levels, and the extracellular actions, of these proteases.  
Additionally, cleavage of CD18 integrins under fluid flow also requires conformational 
changes in their extracellular domains[96]. Conformational activity of CD18 integrins 
involves shifts in the protein tertiary structure from a closed-bent to an open-extended 
configuration[96]. In the case of cytokine stimulation, this conformational change exposes 
ligand binding sites[101] that promote cell capture onto the vessel wall[95, 102]. Another 
consequence of CD18 conformational changes, which occur upon shear stress exposure, is to 
expose proteolytic cleavage sites[96]. With this evidence in mind, it is apparent that the 
physicochemical state of the cell membrane is a key factor in neutrophil mechanosensitivity 
that directly or indirectly affects the ability of shear stress to unfold the CD18 ectodomain. 
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5.2.3. RNS and ROS in shear mechanotransduction  
Reactive nitrogen species (RNS; e.g., NO) and ROS are multi-functional free radical 
mediators of acute inflammation serving not only as anti-microbial agents but also as 
biological second messengers that influence leukocyte functions (e.g., chemotaxis, 
phagocytosis, etc.)[103, 104]. NO from exogenous and endogenous sources (such as 
membrane-associated NO synthase) inhibits neutrophil recruitment out of the 
microvasculature during acute inflammation[105, 106]. Interestingly, NO also enhances 
neutrophil pseudopod retraction in response to shear stress and counteracts the blocking 
effects of cell agonists (e.g. fMLP and platelet-activating factor)[81]. In contrast, ROS, 
particularly O2-, interferes with the neutrophil shear response and is thought to contribute to 
the blocking effects of cell agonist, e.g. fMLP, on flow-induced pseudopod retraction[84].  
Notably, the fact that inhibition of NO synthase activity in neutrophils has no effect on 
shear-induced pseudopod retraction[81] points to an exogenous source and an extracellular 
role for NO. This finding leaves open the possibility that the facultative effects of NO on the 
neutrophil shear response (i.e., pseudopod retraction) result from its ability to scavenge O2-
[103] and, in this way, mediate cell pseudopod activity[107, 108]. In support of this, SOD (an 
O2- scavenger) also enhances the shear responses of fMLP-stimulated neutrophils[84]. Thus, 
O2- is a critical mediator for neutrophil shear response. Since the cell membrane, particularly 
cholesterol-enriched lipid rafts, plays an important role in regulating the production/release 
of O2-[109], its state may indirectly influence neutrophil mechanosensitivity to shear stress.  
5.3. Neutrophil mechanosensitivity and cardiovascular disease 
The accumulated evidence reported in the vascular mechanotransduction literature (see 
reviews[23, 78]) points to the following general paradigm. Exposure of vascular cells to 
physiological flows under normal (i.e., non-diseased, non-inflamed) conditions correlates 
with quiescence (i.e., baseline activity). This paradigm resulted from a multitude of studies 
that selectively examined the activity of various signaling pathways and putative force 
sensors in response to applied mechanical stresses. They, however, overlooked a subtle, but 
equally important, factor: mechanosensitivity or the degree to which cells respond to 
mechanical stresses. Just as biochemical perturbations (e.g. pathogens, inflammatory 
agonists) temporally and dose-dependently alter vascular cell activity leading to 
pathogenesis, so must changes in cell mechanosensitivity impact circulatory health. 
Neutrophils experience wide variations in fluid stresses as they pass through the circulation 
and, thus function “normally” under a diverse array of mechanical stress distributions and 
magnitudes. In other words, aberrant mechanical stresses are unlikely to be a cause of cell 
dysfunction. What may change and contribute to “abnormal” behavior is their sensitivity to 
the surrounding fluid flow mechanoenvironment with a negative impact on the ability of 
fluid shear stress to deactivate the neutrophils. Along this line, the work of Geert Schmid-
Schönbein at the University of California, San Diego has demonstrated that attenuated 
neutrophil shear responses contribute to the microvascular pathobiology observed in 
spontaneously hypertensive rats (SHRs)[110] and, in doing so, illustrated the potential 
impact of impaired shear stress mechanotransduction on cardiovascular health. 
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5.3.1. Impaired fluid shear responses and downstream effects on vascular pathophysiology 
Significant features of the blood from SHRs are elevated numbers of circulating neutrophils, 
suppressed expression of adhesion molecules (e.g., selectins, CD18), and an activated 
phenotype[111-113]. Although the increased activity of neutrophils is not associated with 
increased adhesion to microvascular endothelium[78], their increased numbers raise 
peripheral vascular resistance[110]. One possible explanation is that circulating activated 
neutrophils in SHRs release vasoactive substances that constrict the small arteries and 
arterioles; this has been documented for atherosclerosis[114-116]. Extensive evidence, 
however, points to a hemorheological effect of leukocyte activation on microvascular 
resistance[1, 34, 36]. Specifically, the disturbed motion of white blood cells, due to 
pseudopod projection, significantly reduces erythrocyte velocities in the microcirculation 
increasing hemodynamic resistance and upstream blood pressures[36, 110] (see Figure 1). 
The key evidence for the involvement of fluid flow mechanotransduction in microvascular 
abnormalities due to hypertension is that neutrophils from SHRs lack the ability to retract 
pseudopods in response to shear stress; in some cases, cells extend cellular projections 
under flow stimulation[110]. The underlying mechanism associated with the blockade and 
possible reversal of the pseudopod retraction response to shear stress reportedly involves 
the dependence of blood pressure in SHRs on the plasma level of glucocorticoid-related 
steroid hormones and the density of glucocorticoid receptors on the neutrophil surface[117, 
118]. In line with this, glucocorticoid-treated[119] rats, like SHRs, exhibit elevated peripheral 
resistance in parallel with elevated numbers of neutrophils that lack a pseudopod retraction 
response to shear stress. Taken together, leukocyte shear mechanotransduction appears to be 
critical for the maintenance of a healthy circulation, particularly the microcirculation. Failure of 
this regulatory mechanism, e.g., due to impaired cell mechanosensitivity resulting from a 
pathological blood environment, may not only lead to sustained neutrophil activation but also 
result in disturbed blood flow. In this way, aberrant neutrophil mechanotransduction may 
contribute to microvascular damage that exacerbates ischemia-reperfusion injury or leads to 
peripheral vascular disease and downstream organ/tissue injury. 
Studies on spontaneous hypertension also reveal a key point. Factors that drive phenotypic 
changes in neutrophils (e.g., from an inactivated to an activated state) dramatically alter 
their ability to sense the surrounding flow environment (i.e., mechanosensitivity) leading to 
the development of pathological behavior, including immune suppression. Intuitively, cell 
mechanosensitivity depends on the number and activity of proteins “moonlighting” as 
putative mechanosensors embedded in the cell membrane positioned at the interface 
between the intra- and extra- cellular milieu. These studies further strengthen the argument 
that the plasma membrane is a critical determinant of neutrophil mechanosensitivity. 
5.3.2. The plasma membrane and shear stress mechanosensitivity 
The fact that shear stress-induced neutrophil deactivation (e.g., FPR deactivation, G protein 
signaling, CD18 cleavage, pseudopod retraction, etc.) occurs in the absence of any passive 
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cell deformation due to flow[120] substantiates the presence of a cell surface component(s) 
that transduces flow stimulation. Interestingly, neutrophils retract pseudopods 
independently of the fluid shear stress distribution imposed on the cell surface[82]. Thus, 
membrane properties appear to outweigh the location of mechanosensors on the cell 
surface. Moreover, non-adherent neutrophils respond to shear stress further emphasizing 
the importance of cell membrane-mediated over cell deformation-based (e.g., cytoskeleton-
related, cell adhesion-dependent) neutrophil mechanotransduction.  
The membrane itself may act as a mechanotransducer either via stress-induced changes in 
its fluidity[121-123] or through lipid rafts[62, 63, 124]. However, the concept that the 
membrane serves as a fluid stress sensor lacks the specificity that explains the diversity of 
cell type-specific responses to shear. An alternative, more plausible, viewpoint is that the 
cell membrane serves as mechanotransduction center for the cell. Along this line, the 
specificity associated with mechanotransduction depends on the specific 
mechanoreceptor(s) expressed by the cell. In this regard, a multitude of cell transmembrane 
proteins including various GPCRs[58, 91, 125], tyrosine kinase receptors[126-130], ion 
channels[131], NO synthases, and integrin-associated focal adhesions[132, 133] have been 
implicated as fluid shear stress transducers for a variety of cells (e.g., endothelial cells, 
osteoblasts, neutrophils) and microorganisms (e.g. dino-flagella)[134].  
One potential action of fluid shear stress on transmembrane mechanosensors (e.g., FPR) is 
to alter their surface levels. In the case of GPCRs, exposing migrating neutrophil-like cells 
to parallel plate flow redistributes surface-associated FPRs to a perinuclear compartment 
in the cytosol[135]. These results suggest that internalization of FPRs under fluid shear 
stimulation leads to pseudopod retraction by counteracting their constitutive activity 
which drives pseudopod extension. It should be noted, however, that intact FPR must be 
present since cleavage of FPR is linked to an impaired ability of fluid shear stress to 
promote retraction of neutrophil pseudopods[136]. Since receptor internalization occurs 
across the lipid bilayer, shear-induced changes in mechanoreceptor surface levels may 
thus be a mechanosensitive neutrophil response influenced by properties of the cell 
membrane.  
It is also feasible that the ability of shear stress to alter protein tertiary structure is a function 
of membrane properties. In addition to evidence regarding the influence of shear stress on 
the conformation of FPR and CD18 integrins, fluid flow also alters the structure of other 
membrane-bound GPCRs in other cell types including the bradykinin B2 receptor for 
endothelial cells and the type I parathyroid hormone receptor for osteoblasts[58, 125]. 
Interestingly, physiologically relevant magnitudes of mechanical stresses are capable of 
physically altering the conformation of proteins[132, 133, 137]. Since these proteins are 
embedded in the cell membrane, it is possible that membrane properties influence flow-
related perturbations of protein structure.  
In the end, the physicochemical properties (e.g., fluidity, lipid rafts) of the cell membrane, 
with their influence on the ability of surface mechanosensors to adopt structural shifts under 
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shear, come to the forefront in terms of how hypercholesterolemia modifies neutrophil 
mechanosensitivity. This is the topic of the next section. 
5.3.3. Membrane cholesterol versus membrane fluidity in hypercholesterolemic impairment 
of neutrophil mechanosensitivity  
Hypercholesterolemia is associated with chronic neutrophil activation and elevated blood 
cholesterol as well as cholesterol enrichment in the plasma membranes of blood cells. Based 
on the intimate relationship between protein dynamics (e.g., surface expression, 
conformational activity) and the cell membrane (as described in the previous section), the 
chemical and mechanical properties of the lipid bilayer may be critical determinants of the 
ability of neutrophils to sense fluid shear stress. Along this line, hypercholesterolemia-
related membrane perturbations may reduce the neutrophil responsiveness to shear stress 
by interfering with critical mechanotransduction events, e.g. GPCR and CD18 
conformational activity, protease release, and/or production of ROS, that must 
bidirectionally transmit biological activity across the cell membrane (Figure 4).  
 
Figure 4. Effects of cholesterol abundance on neutrophil mechanotransduction. Elevations in 
extracellular cholesterol lead to membrane cholesterol enrichment which may alter cell 
mechanosensitivity either by influencing shear-induced structural changes of surface sensors, or by 
interfering with shear-induced release of lysosomal proteases. The cell membrane may also influence 
contributions from ROS/RNS (not shown). 
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Figure 5. Relationship between membrane cholesterol-dependent fluidity and neutrophil shear 
responses. A: Recovery effects of benzyl alcohol (BnOH; a membrane fluidizer) on the shear response 
by neutrophils treated with cholesterol-enhancing agents (CH). B: Does-dependent effects of cholesterol 
enrichment on neutrophil shear response and membrane fluidity. Cone-plate shear: 5 dyn/cm2 for 10 
min. Bars are mean percentage of reductions in activated cells by shear ± SEM. *, #p < 0.001 compared to 
untreated cells using Student’s t-test with Bonferrroni’s adjustment.  
Recently, we reported that neutrophil deactivation by shear stress depends on the 
cholesterol-dependent physicochemical properties (i.e., fluidity) of the cell membrane[40]. 
Fundamentally, we showed that the deactivating actions of fluid shear require a cell 
membrane containing an optimal level of cholesterol. Shear stress mechanotransduction is 
impaired if there is too much or too little cholesterol. Moreover, the membrane must be 
capable of supporting the formation of lipid rafts. But, the critical evidence from this work 
are our observations[40] that membrane fluidizer, benzyl alcohol, was capable of 
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cyclodextrin-cholesterol conjugates) and that the concentration of benzyl alcohol to achieve 
this depended on the amount of cholesterol loaded into the neutrophil membranes (Figure 
5A). Thus, there is also an optimal membrane fluidity level permissive for shear-induced 
neutrophil deactivation. This was confirmed by regression analysis[40] which revealed a 
linear relationship (Figure 5B) between membrane cholesterol-related fluidity and the 
degree to which neutrophils within a population are inactivated by fluid flow. Membrane 
cholesterol enrichment therefore impairs neutrophil mechanosensitivity, at least in part, 
through its impact on membrane fluidity.  
Interestingly, neutrophils from LDLr-/- mice fed a HFD exhibit a reduced and even reversed 
shear stress response relative to cells from similar mice maintained on a regular chow (i.e., 
normal) diet (ND)[40]. These observations were consistent with our in vitro data correlating 
membrane cholesterol levels with neutrophil mechanosensitivity[40]. In fact, the shear 
sensitivity of neutrophils from hypercholesterolemic mice tracks negatively with time-
dependent increases in blood levels of cholesterol, particularly of the free form (Figure 6). 
Presumably, the gradual loading of cholesterol into the neutrophil membrane resulting from 
the progressive increases in the cholesterol concentration gradient across the outer leaflet of 
the cell membrane is responsible for the time-dependent decrease in shear 
mechanosensitivity. Impairment of neutrophil shear responses by membrane cholesterol 
enrichment may thus underlie the pathogenesis of hypercholesterolemic disorders via an 
effect on cell membrane fluidity which governs the ability of protein sensors to initiate a 
sufficient degree of mechanotransduction at the cell surface. As such, a chronic 




Figure 6. Correlation between neutrophil shear responses and serum levels of free cholesterol. A: 
LDLr-/- mice on normal diet (ND); B: LDLr-/- mice on high fat diet (HFD). Cone-plate shear: 5 dyn/cm2 
for 10 min. Bars and square dots are mean ± SEM. *, #p < 0.02 compared to 2-week using Student’s t-test 
with Bonferrroni’s adjustment.  
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6. Future directions  
To date, the accumulated evidence strongly points to shear stress mechanotransduction as 
an important negative control mechanism for neutrophils flowing in blood under non-
inflamed conditions and, thus, an important mediator of circulatory homeostasis. For the 
most part, the pathobiology of hypercholesterolemia is a process that takes decades to 
develop into a serious, life-threatening condition and tracks with gradual elevations in 
blood cholesterol levels. In addition, hypercholesterolemia is characterized by a chronic 
inflammatory phenotype associated with elevated levels of neutrophil activity in the blood. 
The question is how these two factors may be related or linked? 
Based on the evidence presented in this chapter, the possibility that elevations in blood 
cholesterol levels impair the neutrophil-deactivating effects of fluid shear stress further 
suggests that vascular mechanotransduction is an important aspect of cardiovascular 
physiology and that the pathobiology of hypercholesterolemia may result, at least in part, 
from a putative disruption of this mechanotransducing function. This statement applies not 
only to neutrophils, but also to other cells in the circulation including the other white cells 
and the endothelium. Moreover, the presented evidence hints at the need to shift focus on 
the study of vascular mechanobiology from characterizing mechanotransduction (i.e., 
identifying mechanobiological signaling) in disease to actively investigating the influence of 
mechanosensitivity (i.e. the degree to which cells transduce fluid stresses) on vascular 
pathogenesis. In our case, we linked altered neutrophil mechanosensitivity with the gradual 
changes in blood cholesterol levels and leukocyte membranes during the development of 
hypercholesterolemia in LDLr-/- mice fed a fat-enriched diet. In light of our own evidence 
and those of others[3, 4, 8] showing that shear stress is anti-inflammatory for neutrophils, it 
is possible that a putative source of vascular dysfunction causal for hypercholesterolemic 
pathobiology is the aberrant neutrophil mechanosensitivity. 
Despite recognition that vascular mechanotransduction is critical for circulatory 
homeostasis, there are no markers currently in use or, to our knowledge, in development 
that account for mechanosensitivity to predict vascular inflammatory status. Current 
indicators of inflammation include C-reactive protein (CRP; >3 mg/L is at cardiovascular 
risk) and serum amyloid protein A (SAA; >10 mg/L is at cardiovascular risk). But even 
though these two biochemical markers are the gold standard measures of inflammatory 
activity for blood[138, 139], they are upregulated when leukocyte activity levels are already 
elevated. It is thus not clear whether these molecules are viable “predictors” or just 
indicators of chronic inflammatory disorders. As such, understanding, characterizing, and 
formulating measures of neutrophil mechanosensitivity may prove useful in revealing 
earlier clues regarding the state of inflammation in blood.  
In the end, the likelihood that a cholesterol-dependent loss of neutrophil sensitivity to fluid 
flow stimuli leads to pathological situations implicates a wide range of cardiovascular (and 
non-cardiovascular) diseases that correlate with both chronic inflammation and an altered 
cholesterol environment, e.g. hypercholesterolemia and diabetes[74, 140]. The critical issues 
are to increase efforts to define the link between chronic inflammation and impaired 
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neutrophil mechanotransduction and to determine if chronic inflammation precedes or 
results from an impairment of vascular mechanotransduction. Further work is, therefore, 
needed to determine mechanistic-level connections between the cell surface, the flow 
sensors, the extracellular flow environment, and the influence of a hypercholesterolemic 
environment on these. The hope is that by fully defining the role of fluid mechanics in the 
physiological regulation of leukocytes, particularly the neutrophils, one may gain a better 
understanding of their role in the pathogenesis of cardiovascular disease. 
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